Study of Electronic Brachytherapy for Cutaneous Basal Cell Carcinoma
NCT02939027 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2016-10-19
Summary
Electronic brachytherapy (EBT) offers an isotope-free radiation therapy modality for the treatment of specific skin lesions, especially non-melanoma skin cancers (NMSC). Within the treatment of NMSC, surgical removal of the lesion is currently the treatment of choice for the majority of cases. However in an estimated 10-15% of NMSC patients, surgery might not be the best treatment option. Location of the tumour in cosmetically sensitive areas, patient comorbidities, old age, use of anti-coagulation etc. might all be reasons to select radiotherapy as first choice of treatment. The objective of ths study will be to determine histologically confirmed clinical efficacy, safety, and usability of Electronic Brachytherapy, an innovative treatment for Basal Cell Carcinoma (BCC).
Conditions
- Carcinoma, Basal Cell
Interventions
- DEVICE
-
Electronic Brachytherapy (6,1 Gy)
A total dose of 36.6 Gy is planned over 6 fractions of 6.1 Gy, given 2 days/week, during 3 weeks or lees, at least 2 days apart each fraction.
- DEVICE
-
Electronic Brachytherapy (7 Gy)
A total a dose of 42 Gy is planned over 6 fractions of 7 Gy, given 2 days/week during 3 weeks or lees, at least 2 days apart each fraction.
Sponsors & Collaborators
-
Instituto de Investigacion Sanitaria La Fe
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2016-07-31
- Completion
- 2016-07-31
More Related Trials
-
Radiotherapy Treatment Planning Comparison Using SBRT-PATHY (Photons) Versus CARBON-PATHY for Unresectable Bulky Tumors
NCT06390657 ·Status: WITHDRAWN
-
Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas
NCT03989596 ·Status: UNKNOWN ·Phase: PHASE2
-
5 Fraction Stereotactic Body Radiation Therapy for Oligometastases Regimen, for Extra-Cranial Oligometastases
NCT01761929 ·Status: COMPLETED ·Phase: PHASE2
-
Ablative SBRT in Elderly BC Patients
NCT06523894 ·Status: RECRUITING ·Phase: NA
-
Randomized Carbon Ions vs Standard Radiotherapy for Radioresistant Tumors
NCT02838602 ·Status: RECRUITING ·Phase: NA
-
Hyperthermia With Flexible Electrode-typed 2-MHz Device During Radiotherapy for Solid Tumors
NCT05282784 ·Status: UNKNOWN ·Phase: NA
-
Study of External Beam Radiotherapy to Thyroid Carcinoma
NCT01173289 ·Status: COMPLETED ·Phase: PHASE2
-
Stereotactic Body Radio Therapy (SBRT) for Early-stage Non Small Cell Lung Cancer (NSCLC)
NCT00870116 ·Status: UNKNOWN ·Phase: NA
-
A Study on Radiation Therapy Guided by the Reflectance Confocal Microscopy (RCM)/Optical Coherence Tomography (OCT) Device in People With Basal Cell Carcinoma
NCT05294120 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma
NCT02795195 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Simultaneous Integrated Boost in Carbon Ion Radiotherapy for Head and Neck Adenoid Cystic Carcinoma
NCT05733910 ·Status: RECRUITING ·Phase: NA
-
Radiotherapy in Association With Cetuximab in Patients Treated for an Epidermoid Cancer
NCT01647555 ·Status: COMPLETED
-
Safety and Efficacy of SBRT in the Reirradiation for Ultra-central Thoracic Malignant Tumors
NCT05189054 ·Status: RECRUITING
-
SBRT + Immunomodulating Systemic Therapy for Inoperable, Recurrent H&N
NCT03402737 ·Status: TERMINATED ·Phase: NA
-
Stereotactic Radiosurgery in Patients With Head and Neck Region Tumours
NCT06472570 ·Status: RECRUITING ·Phase: NA
-
Hypofractionated Radiotherapy in Breast Cancer
NCT03167359 ·Status: COMPLETED ·Phase: NA
-
Atezolizumab and BEvacizumab With STereotactic Body Radiotherapy for Advanced Hepatocellular Carcinoma
NCT06595108 ·Status: RECRUITING ·Phase: NA
-
Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer
NCT02379039 ·Status: COMPLETED
-
Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissue Tumors, MBRT1 Trial
NCT07062003 ·Status: RECRUITING ·Phase: NA
-
Assessment of Different Therapeutic Strategies in Patients With Head and Neck Neoplasms Treated With Radiotherapy
NCT06773039 ·Status: RECRUITING
-
Stereotactic Body Radiotherapy (SBRT) for Spinal/Para-Spinal Metastases (Spine SBRT)
NCT01290562 ·Status: COMPLETED ·Phase: PHASE2
-
Stereotactic Ablative Body Radiotherapy (SABR) for Oligometastases
NCT02933242 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Individualized Stereotactic Body Radiotherapy of Liver Metastases
NCT01239381 ·Status: COMPLETED ·Phase: NA
-
MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer
NCT02582931 ·Status: COMPLETED ·Phase: PHASE1
-
Phase II Trial of SBRT Compared With Conventional Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer
NCT02975609 ·Status: UNKNOWN ·Phase: PHASE2